Aura Biosciences Inc (AURA)

Aura Biosciences Inc (AURA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $678M; returns 1 day -2.5%, 1 week +3.3%, 1 year +10.9%.

Aura Biosciences Inc. is a clinical-stage biotechnology company headquartered in Boston, MA, focused on developing a novel class of precision immunotherapies known as Virus-Like Drug Conjugates (VDCs) for the treatment of various solid tumors while aiming to preserve organ function.

Groups AURA belongs to

• Biotechnology
• Clinical Stage Biotech
• Oncology
• Healthcare
• Ophthalmology
• Precision Medicine
• Immunotherapy
• Rare Diseases
• Drug Discovery
• Life Sciences

AURA financial model: income statement, cash flow and balance sheet